FDA — authorised 14 December 2012
- Application: NDA203993
- Marketing authorisation holder: LUNDBECK PHARMS LLC
- Local brand name: ONFI
- Indication: SUSPENSION — ORAL
- Status: approved
🇺🇸 Clobazam Low Dose in United States
FDA authorised Clobazam Low Dose on 14 December 2012
Marketing authorisation
Other Neurology approved in United States
Frequently asked questions
Is Clobazam Low Dose approved in United States?
Yes. FDA authorised it on 14 December 2012.
Who is the marketing authorisation holder for Clobazam Low Dose in United States?
LUNDBECK PHARMS LLC holds the US marketing authorisation.